Keenova Therapeutics plc announced the first-time publication of a retrospective analysis using previously generated XIAFLEX® (collagenase clostridium histolyticum) data. The analysis evaluates ...

The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...

Ahead of this week's Opening Ceremony at the Winter Olympics in Milan, the World Anti-Doping Agency has addressed claims originating from a German tabloid that male skiers could be injecting ...

One day before the Opening Ceremony at the Winter Olympics in Milan, officials from the World Anti-Doping Agency addressed claims in a German tabloid that male skiers could be injecting their penises ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

AstraZeneca AZN-1.16%decrease; red down pointing triangle said the U.S. Food and Drug Administration rejected an initial submission for its Saphnelo lupus drug in injection form, and vowed to work ...

Dupuytren’s contracture can worsen over time if not treated, leading to fingers bending permanently toward the palm and potentially requiring surgery to regain function. The condition can ...

The claim: To defend recent changes to the childhood vaccine schedule, the Trump administration compared shots for American babies with babies in an unspecified "European Country." The Jan. 5 White ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

This marks the first live procedure at AAHS, as well as a first for Keenova. Treatment takes place over two days of annual meeting—injection on Wednesday and finger extension on Friday. Audience of ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...